BioAge posts double-digit percentage jump after IPO; natural-gas producer BKV pares gains in debut
Obesity-drug developer BioAge Labs Inc. gained about 20% after its initial public offering on Thursday, while natural-gas producer BKV Inc. was up fractionally over its $18 IPO price. BioAge shares opened at $22.
Natural gas producer BKV raises $270 million in US IPO
Natural gas producer BKV Corp said on Wednesday it had raised $270 million in its U.S. initial public offering.
A weight loss drug developer's stock soars after a $198 million IPO
Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public offering (IPO) price on Thursday.
Natural-gas producer BKV and drug-developer BioAge queue up IPOs
Texas-based Barnett Shale driller prices below the estimated range, while obesity-drug developer BioAge prices midrange ahead of trading.
Weight-loss drug developer BioAge raises $198 million in U.S. IPO
(Reuters) -BioAge Labs has raised $198 million after pricing its upsized U.S. initial public offering at the midpoint of the targeted range at $18 per share, the weight-loss drug developer said on Wednesday.
A weight loss drug maker is aiming for a big IPO
BioAge Labs, a biopharmaceutical startup focused on obesity drugs, is looking to raise nearly $200 million in its recently expanded, planned initial public offering, according to a filing with the U.S.
Weight-loss drug developer BioAge Labs aims to raise $198M from U.S. IPO
Weight-loss drug developer BioAge Labs (BIOA) on Wednesday announced the pricing of its upsized initial public offering of 11,000,000 shares of its common stock at a public offering price of $18.00 per share.
Hart Energy1d
BKV Prices IPO at $270MM Nearly Two Years After First Filing
BKV Corp. priced its common shares at $18 each after and will begin trading on Sept. 26, about two years after the Denver ...
Morningstar11h
BioAge, BKV shares end their first trading day flat after earlier gains
Obesity-drug developer BioAge holds on to a slim gain, while Texas-based Barnett Shale driller BKV trades flat Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell ...
Weirton Daily Times2d
‘Shale Revolution’: A look back at 20 years of gas drilling in the region
It is pleasant, to be sure, a friendly, bucolic town of about 3,300 residents nestled in its gently rolling hills. Shane […] ...
Hart Energy10d
Barnett Shale’s BKV to Launch Delayed IPO of Natgas-focused E&P
BKV Corp. has positioned itself as an LNG supplier near Gulf Coast markets with production averaging 718 MMcfe/d across about ...
Stock Market Today: Dow up 200 points, S&P 500 hits record high after upbeat economic data
Texas-based Barnett Shale driller BKV Inc. priced below the estimated range, while obesity-drug developer BioAge Labs Inc. priced midrange ahead of their first day of trading on Thursday. As the ...
Fort Worth Report8d
After two rejections, proposal to expand natural gas drilling near Arlington day care returns
Residents are pushing back against French company TotalEnergies’ latest proposal, citing research about the impact of fracking on children’s health.
Midland Reporter-Telegram5d
West Texas Geological Society symposium offers 'Permian 101' lesson on shale production
The West Texas Geological Society’s fall symposium featured a comprehensive 'Permian 101' lesson on the history and ...